Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
426,146
-
Share change
-
-54,517
-
Total reported value
-
$262,014
-
Price per share
-
$0.61
-
Number of holders
-
9
-
Value change
-
-$39,911
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q4 2022
As of 31 Dec 2022,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
426,146 shares.
The largest 9 holders included
MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, OLD MISSION CAPITAL LLC, TWO SIGMA SECURITIES, LLC, UBS Group AG, Belpointe Asset Management LLC, WELLS FARGO & COMPANY/MN, Steward Partners Investment Advisory, LLC, and AdvisorNet Financial, Inc.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.